From:
`To:
`
`Subject:
`Date:
`
`Megan Raymond
`Trials; Molenda, John; Underwood, Cathy; white-ptab@perkinscoie.com; greb-ptab@perkinscoie.com; prochnow-
`ptab@perkinscoie.com; jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com; lembo-ptab@perkinscoie.com;
`J. Steven Baughman; Green, Michael; Doh, Tyler; Kass, Lawrence; Michael Milea; Joshua Reich; [MtrDist]
`Semaglutide
`IPR2024-00631
`Monday, March 11, 2024 11:11:14 AM
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Petitioner filed Paper 4 and Exhibit 1507 under seal in the above-reference matter, with
`“Availability” through P-TACTS set for only the Filing Party and Board. Under 37 CFR
`42.55, Patent Owner hereby consents to the default protective order and requests access to the
`paper and exhibit through P-TACTS.
`
`Sincerely,
`Megan Raymond
`Counsel for Patent Owner
`
`From: Trials <Trials@USPTO.GOV>
`Sent: Monday, March 11, 2024 10:33 AM
`To: Megan Raymond <megan.raymond@groombridgewu.com>; Molenda, John
`<jmolenda@Steptoe.com>; Underwood, Cathy <Cathy.Underwood@USPTO.GOV>; white-
`ptab@perkinscoie.com; greb-ptab@perkinscoie.com; prochnow-ptab@perkinscoie.com; jones-
`ptab@perkinscoie.com; tietz-ptab@perkinscoie.com; lembo-ptab@perkinscoie.com; J. Steven
`Baughman <steve.baughman@groombridgewu.com>; Green, Michael <migreen@steptoe.com>;
`Doh, Tyler <tdoh@steptoe.com>; Kass, Lawrence <lkass@steptoe.com>; Michael Milea
`<mike.milea@groombridgewu.com>; Joshua Reich <joshua.reich@groombridgewu.com>; [MtrDist]
`Semaglutide <Semaglutide@Steptoe.com>
`Cc: Trials <Trials@USPTO.GOV>
`Subject: RE: Conference Call - IPR2023-00724 and IPR2024-00631
`
`Counsel,
`
`The conference call dial-in number is:
`
` and the passcode is:
`
`.
`
`Regards,
`
`Esther Goldschlager
`Supervisory Paralegal Specialist
`Patent Trial & Appeal Board
`U.S. Patent & Trademark Office
`
`From: Megan Raymond <megan.raymond@groombridgewu.com>
`
`Exhibit 3001
`
`
`To:
`
`Subject:
`Date:
`
`Megan Raymond
`Trials; Molenda, John; Underwood, Cathy; white-ptab@perkinscoie.com; greb-ptab@perkinscoie.com; prochnow-
`ptab@perkinscoie.com; jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com; lembo-ptab@perkinscoie.com;
`J. Steven Baughman; Green, Michael; Doh, Tyler; Kass, Lawrence; Michael Milea; Joshua Reich; [MtrDist]
`Semaglutide
`IPR2024-00631
`Monday, March 11, 2024 11:11:14 AM
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Petitioner filed Paper 4 and Exhibit 1507 under seal in the above-reference matter, with
`“Availability” through P-TACTS set for only the Filing Party and Board. Under 37 CFR
`42.55, Patent Owner hereby consents to the default protective order and requests access to the
`paper and exhibit through P-TACTS.
`
`Sincerely,
`Megan Raymond
`Counsel for Patent Owner
`
`From: Trials <Trials@USPTO.GOV>
`Sent: Monday, March 11, 2024 10:33 AM
`To: Megan Raymond <megan.raymond@groombridgewu.com>; Molenda, John
`<jmolenda@Steptoe.com>; Underwood, Cathy <Cathy.Underwood@USPTO.GOV>; white-
`ptab@perkinscoie.com; greb-ptab@perkinscoie.com; prochnow-ptab@perkinscoie.com; jones-
`ptab@perkinscoie.com; tietz-ptab@perkinscoie.com; lembo-ptab@perkinscoie.com; J. Steven
`Baughman <steve.baughman@groombridgewu.com>; Green, Michael <migreen@steptoe.com>;
`Doh, Tyler <tdoh@steptoe.com>; Kass, Lawrence <lkass@steptoe.com>; Michael Milea
`<mike.milea@groombridgewu.com>; Joshua Reich <joshua.reich@groombridgewu.com>; [MtrDist]
`Semaglutide <Semaglutide@Steptoe.com>
`Cc: Trials <Trials@USPTO.GOV>
`Subject: RE: Conference Call - IPR2023-00724 and IPR2024-00631
`
`Counsel,
`
`The conference call dial-in number is:
`
` and the passcode is:
`
`.
`
`Regards,
`
`Esther Goldschlager
`Supervisory Paralegal Specialist
`Patent Trial & Appeal Board
`U.S. Patent & Trademark Office
`
`From: Megan Raymond <megan.raymond@groombridgewu.com>
`
`Exhibit 3001
`
`
`
`Sent: Monday, March 11, 2024 10:29 AM
`To: Molenda, John <jmolenda@Steptoe.com>; Underwood, Cathy
`<Cathy.Underwood@USPTO.GOV>; white-ptab@perkinscoie.com; greb-ptab@perkinscoie.com;
`prochnow-ptab@perkinscoie.com; jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com;
`lembo-ptab@perkinscoie.com; J. Steven Baughman <steve.baughman@groombridgewu.com>;
`Green, Michael <migreen@steptoe.com>; Doh, Tyler <tdoh@steptoe.com>; Kass, Lawrence
`<lkass@steptoe.com>; Michael Milea <mike.milea@groombridgewu.com>; Joshua Reich
`<joshua.reich@groombridgewu.com>; [MtrDist] Semaglutide <Semaglutide@Steptoe.com>
`Cc: Trials <Trials@USPTO.GOV>
`Subject: RE: Conference Call - IPR2023-00724 and IPR2024-00631
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Hello,
`
`The passcode for this call does not seem to be valid.
`
`Sincerely,
`Megan Raymond
`
`From: Megan Raymond <megan.raymond@groombridgewu.com>
`Sent: Friday, March 8, 2024 10:46 AM
`To: Molenda, John <jmolenda@Steptoe.com>; Underwood, Cathy
`<Cathy.Underwood@USPTO.GOV>; white-ptab@perkinscoie.com; greb-ptab@perkinscoie.com;
`prochnow-ptab@perkinscoie.com; jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com;
`lembo-ptab@perkinscoie.com; J. Steven Baughman <steve.baughman@groombridgewu.com>;
`Green, Michael <migreen@steptoe.com>; Doh, Tyler <tdoh@steptoe.com>; Kass, Lawrence
`<lkass@steptoe.com>; Michael Milea <mike.milea@groombridgewu.com>; Joshua Reich
`<joshua.reich@groombridgewu.com>; [MtrDist] Semaglutide <Semaglutide@Steptoe.com>
`Cc: Trials <Trials@USPTO.GOV>
`Subject: Re: Conference Call - IPR2023-00724 and IPR2024-00631
`
`We have received the email regarding Monday’s call with the Board.
`
`Sincerely,
`Megan Raymond
`
`Groombridge, Wu, Baughman & Stone LLP
`801 17th Street, NW, Suite 1050
`Washington, DC 20006
`O +1 202-505-5878, M +1 617-388-5878
`megan.raymond@groombridgewu.com
`
`
`From: Molenda, John <jmolenda@Steptoe.com>
`
`
`
`Sent: Friday, March 8, 2024 10:36:44 AM
`To: Underwood, Cathy <Cathy.Underwood@USPTO.GOV>; white-ptab@perkinscoie.com <white-
`ptab@perkinscoie.com>; greb-ptab@perkinscoie.com <greb-ptab@perkinscoie.com>; prochnow-
`ptab@perkinscoie.com <prochnow-ptab@perkinscoie.com>; jones-ptab@perkinscoie.com <jones-
`ptab@perkinscoie.com>; tietz-ptab@perkinscoie.com <tietz-ptab@perkinscoie.com>; lembo-
`ptab@perkinscoie.com <lembo-ptab@perkinscoie.com>; J. Steven Baughman
`<steve.baughman@groombridgewu.com>; Megan Raymond
`<megan.raymond@groombridgewu.com>; Green, Michael <migreen@Steptoe.com>; Doh, Tyler
`<tdoh@Steptoe.com>; Kass, Lawrence <lkass@Steptoe.com>; Michael Milea
`<mike.milea@groombridgewu.com>; Joshua Reich <joshua.reich@groombridgewu.com>; [MtrDist]
`Semaglutide <Semaglutide@Steptoe.com>
`Cc: Trials <Trials@USPTO.GOV>
`Subject: RE: Conference Call - IPR2023-00724 and IPR2024-00631
`
`
`Some people who received this message don't often get email from jmolenda@steptoe.com. Learn why this is
`important
`Dear Cathy,
`
`Counsel for Apotex Inc. have received your email and will plan accordingly.
`
`Best regards,
`John Molenda
`
`John Josef Molenda, Ph.D.
`Partner
`Co-Chair, Healthcare & Life Sciences Practice
`Pronouns: he/him/his
`Steptoe
`Steptoe LLP | 1114 Avenue of the Americas | New York, NY 10036
`+1 212 378 7540 direct | +1 917 549 2189 mobile | +1 212 506 3950 fax | jmolenda@Steptoe.com |
`www.steptoe.com
`John Molenda’s biography
`
`
`From: Underwood, Cathy <Cathy.Underwood@USPTO.GOV>
`Sent: Friday, March 8, 2024 10:30 AM
`To: white-ptab@perkinscoie.com; greb-ptab@perkinscoie.com; prochnow-ptab@perkinscoie.com;
`jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com; lembo-ptab@perkinscoie.com;
`steve.baughman@groombridgewu.com; megan.raymond@groombridgewu.com; Molenda, John
`<jmolenda@Steptoe.com>; Green, Michael <migreen@Steptoe.com>; Doh, Tyler
`<tdoh@Steptoe.com>; Kass, Lawrence <lkass@Steptoe.com>; mike.milea@groombridgewu.com;
`joshua.reich@groombridgewu.com
`Cc: Trials <Trials@USPTO.GOV>
`Subject: [EXTERNAL] Conference Call - IPR2023-00724 and IPR2024-00631
`
`
`
`
`Counsel,
`
`A conference call in the above mentioned cases is scheduled
`for Monday, March 11 at 10:30 AM ET.
`
`The call in number is
`.
`
` and the passcode is
`
`
`Joining a conference:
`1. You must use a touch-tone phone to participate in an
`Instant Meeting conference.
`2. Dial the appropriate access number.
`Participants: Enter your numeric participant passcode
`followed by a # sign.
`
`If you have any questions, please feel free to contact me.
`Please confirm receipt of this email.
`
`
`
`
`Thank you,
`Cathy Underwood
`Trial Paralegal
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`cathy.underwood@uspto.gov
`(DIRECT) 571-272-8358
`(MAIN) 571-272-9797
`
`
`This message is intended only for the use of the addressee and may contain confidential and
`privileged information. Any review, use, or dissemination by anyone other than the addressee is
`strictly prohibited. If you received this message in error, please notify us and delete all copies of this
`message.
`
`This message is intended only for the use of the addressee and may contain confidential and
`privileged information. Any review, use, or dissemination by anyone other than the addressee is
`strictly prohibited. If you received this message in error, please notify us and delete all copies of this
`message.
`
`This message is intended only for the use of the addressee and may contain confidential and
`privileged information. Any review, use, or dissemination by anyone other than the addressee is
`strictly prohibited. If you received this message in error, please notify us and delete all copies of this
`
`
`
`message.
`
`This message is intended only for the use of the addressee and may contain confidential and
`privileged information. Any review, use, or dissemination by anyone other than the addressee
`is strictly prohibited. If you received this message in error, please notify us and delete all
`copies of this message.
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
